鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/07/16 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 24,600 |
2025/07/15 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 12,700 |
2025/07/14 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 8,400 |
2025/07/11 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 3,900 |
2025/07/10 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 17,400 |
2025/07/09 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 10,000 |
2025/07/08 | 6,330 | 6,340 | 6,320 | 6,320 | -10 | -0.2% | 20,800 |
2025/07/07 | 6,330 | 6,360 | 6,330 | 6,330 | +10 | +0.2% | 22,100 |
2025/07/04 | 6,330 | 6,330 | 6,320 | 6,320 | -10 | -0.2% | 18,200 |
2025/07/03 | 6,320 | 6,330 | 6,320 | 6,330 | ±0 | ±0% | 9,300 |
2025/07/02 | 6,320 | 6,330 | 6,320 | 6,330 | +10 | +0.2% | 30,500 |
2025/07/01 | 6,320 | 6,320 | 6,320 | 6,320 | ±0 | ±0% | 19,400 |
2025/06/30 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 31,400 |
2025/06/27 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 28,400 |
2025/06/26 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 52,100 |
2025/06/25 | 6,320 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 34,300 |
2025/06/24 | 6,330 | 6,330 | 6,320 | 6,320 | ±0 | ±0% | 90,900 |
2025/06/23 | 6,320 | 6,330 | 6,320 | 6,320 | -10 | -0.2% | 71,000 |
2025/06/20 | 6,330 | 6,330 | 6,320 | 6,330 | +10 | +0.2% | 64,300 |
2025/06/19 | 6,340 | 6,370 | 6,320 | 6,320 | -20 | -0.3% | 26,300 |
2025/06/18 | 6,330 | 6,420 | 6,330 | 6,340 | +10 | +0.2% | 48,400 |
2025/06/17 | 6,330 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 10,800 |
2025/06/16 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 26,100 |
2025/06/13 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 34,200 |
2025/06/12 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 92,500 |
2025/06/11 | 6,340 | 6,350 | 6,340 | 6,340 | ±0 | ±0% | 37,300 |
2025/06/10 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 94,300 |
2025/06/09 | 6,340 | 6,350 | 6,330 | 6,340 | ±0 | ±0% | 121,000 |
2025/06/06 | 6,340 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 47,900 |
2025/06/05 | 6,340 | 6,350 | 6,330 | 6,330 | ±0 | ±0% | 404,600 |
2025/06/04 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 121,000 |
2025/06/03 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 87,700 |
2025/06/02 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 40,800 |
2025/05/30 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 61,300 |
2025/05/29 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 70,000 |
2025/05/28 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 47,900 |
2025/05/27 | 6,340 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 60,000 |
2025/05/26 | 6,340 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 89,900 |
2025/05/23 | 6,340 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 87,200 |
2025/05/22 | 6,340 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 49,800 |
2025/05/21 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 122,800 |
2025/05/20 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 150,200 |
2025/05/19 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 121,700 |
2025/05/16 | 6,330 | 6,340 | 6,330 | 6,330 | -10 | -0.2% | 98,000 |
2025/05/15 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 166,700 |
2025/05/14 | 6,330 | 6,340 | 6,330 | 6,340 | ±0 | ±0% | 277,000 |
2025/05/13 | 6,330 | 6,340 | 6,330 | 6,340 | +10 | +0.2% | 206,400 |
2025/05/12 | 6,330 | 6,340 | 6,330 | 6,330 | ±0 | ±0% | 526,000 |
2025/05/09 | 6,340 | 6,350 | 6,330 | 6,330 | -10 | -0.2% | 950,900 |
2025/05/08 | 6,350 | 6,350 | 6,330 | 6,340 | +760 | +13.6% | 3,056,000 |
1~
50
件表示中 / 3743件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 162,600円 | +5.0% | +1.5% | 0.00% | 13.91倍 | 3.70倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 418,500円 | +3.6% | +6.1% | 2.87% | 14.10倍 | 0.83倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 382,100円 | -6.4% | -71.8% | 4.97% | 42.68倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 315,500円 | +7.9% | -3.3% | 2.54% | 8.77倍 | 0.90倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム